Department of Oncology Lecturer, Dr Lennard Lee was nominated by The Academy of Medical Sciences for safeguarding cancer and immunocompromised patients during the coronavirus pandemic and innovations in cancer diagnostics.
As part of selection into this group, Lennard met other young physician leaders from across the world in Berlin in October 2022 to harnesses the expertise of the world’s leading scientific minds to advance sound policies, improve public health and promote excellence in science education. He also was given the opportunity to present at the World Health Summit in Berlin a “global pact to protect those with cancer and the immunocompromised”
I am thrilled to be given this accolade for the United Kingdom. We have done so much work in the UK to safeguard cancer patients, including work showing that it was safe to deliver chemotherapy during the pandemic. Oxford University has delivered the largest global studies into vaccine effectiveness for cancer patients through the UK COVID Cancer Programme. My work would not be possible without the training and support that I have received from the Department of Oncology, Oxford University Hospitals, and the Oxford University Clinical Academic Graduate School and I am immensely grateful for their support and training - Dr Lennard Lee
Lennard is a great candidate and an excellent example of young physician leadership. We are delighted in getting him to share his contribution and insights at this international event in 2022 - Dr Peter McGrath, awarding panel from the global InterAcademy Partnership
Read about the other 2022 award winners.